Key facts
- This page summarizes William Guyer's Form 3 filing for CORCEPT THERAPEUTICS INC (CORT).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 19 Aug 2021, 21:15.
William Guyer - 16 Aug 2021 Form 3 Insider Report for CORCEPT THERAPEUTICS INC (CORT)
- Reporting relationship
- Chief Development Officer
- Issuer ticker
- CORT
- Reported as of
- 16 Aug 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 19 Aug 2021, 21:15:02 UTC
- Next SEC filing
- 03 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph Douglas Lyon, Attorney-in-Fact for William Guyer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
William Guyer filed Form 3 for CORCEPT THERAPEUTICS INC (CORT) on 19 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.